Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults
ABSTRACT: Objectives: Vancomycin remains a first-line treatment for methicillin-resistant Staphylococcus aureus (MRSA)-mediated acute pulmonary exacerbations (APEs) in adult cystic fibrosis (CF) patients; however, optimal alternatives remain poorly defined.The aim of this study was to determine the safety and efficacy of ceftaroline for MRSA-mediat